Optimalisation of Therapeutic Drug Monitoring (TDM) of Vancomycin in Patients With Central Venous Port Devices

NCT01661361 · clinicaltrials.gov ↗
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Universitaire Ziekenhuizen KU Leuven